首页> 外文期刊>The Journal of Urology >Experience with lyophilized human dura mater for urethral strictures.
【24h】

Experience with lyophilized human dura mater for urethral strictures.

机译:冻干人硬脑膜治疗尿道狭窄的经验。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We report our results using lyophilized human dura mater for urethral strictures. MATERIALS AND METHODS: The results of 131 urethroplasties using lyophilized human dura mater grafts were reviewed. The etiology of the stricture was unknown in most cases and 44.3% had not been previously treated. Mean stricture length was 10 cm. A dura mater patch was used in 124 cases and tubular graft in 7. RESULTS: Average followup was 56.6 months. The overall complication rate during the first month was 16.3%. At 6 months the graft failed in 2 cases and 25.2% had stricture recurrence. Good results were obtained in the longer term in 41.1% of cases, with a high recurrence rate and malignancy in 4 cases (3.2%) which required penectomy. CONCLUSIONS: Despite being a biologically well tolerated material, lyophilized human dura mater is not good for urethral strictures because of the high number of relapses and possibility of malignancy.
机译:目的:我们报告使用冻干的人类硬脑膜治疗尿道狭窄的结果。材料与方法:回顾了使用冻干人硬脑膜移植物进行131例尿道成形术的结果。在大多数情况下,狭窄的病因尚不清楚,并且先前未曾治疗过44.3%。平均狭窄长度为10厘米。硬脑膜贴剂124例,肾小管移植7例。结果:平均随访56.6个月。第一个月的总并发症发生率为16.3%。在6个月时,有2例移植失败,25.2%的患者再次狭窄。从长远来看,有41.1%的病例获得了良好的效果,其中有4例(3.2%)的复发率和恶性程度高,需要进行全切除术。结论:尽管冻干人硬脑膜是一种生物学耐受性良好的材料,但由于其复发率高且有发生恶性肿瘤的可能性,因此不利于尿道狭窄。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号